Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Virology, Epidemiology, Pathogenesis, and Control of COVID-19

Yuefei Jin, Haiyan Yang, Wangquan Ji, Weidong Wu, Shuai-yin Chen, Wei-Guo Zhang, Guangcai Duan

The outbreak of emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) disease (COVID-19) in China has been brought to global attention and declared a pandemic by the World Health Organization (WHO) on March 11, 2020. Scientific advancements since the pandemic of severe acute respiratory syndrome (SARS) in 2002~2003 and Middle East respiratory syndrome (MERS) in 2012 have accelerated our understanding of the epidemiology and pathogenesis of SARS-CoV-2 and the development of therapeutics to treat viral infection. As no specific therapeutics and vaccines are available for disease control, the epidemic of COVID-19 is posing a great threat for global public health. To provide a comprehensive summary to public health authorities and potential readers worldwide, we detail the present understanding of COVID-19 and introduce the current state of development of measures in this review.

2020

SARS-CoV-2, COVID-19, Epidemiology, pathogenesis, therapeutics

DOI: 10.3390/v12040372

Viruses

MDPI AG

Microbiology

EN